Blog
October. 21 2026

Ceramide NP is insoluble in water and has limited solubility in cosmetic carrier systems. Its supplied form determines how it enters a formula. Powder is incorporated through a suitable heated oil phase, while a liposomal grade carries NP into an aqueous formula as a dispersion. Water dispersibility describes that carrier-based form; the NP itself remains water-insoluble.
Initial incorporation and post-cooling stability are separate questions. A batch can look uniform during manufacture yet develop haze or graininess later. For creams, lotions, and aqueous serums, our NP powder and AC-Ceramide NP SANIO address different incorporation needs. The choice brings together the target NP level, the available heating step, and the ingredients that will carry it through the finished formula.
Dissolution distributes the ceramide at a molecular level within a suitable solvent. Dispersion distributes particles or carrier structures through a continuous phase. Melting changes the ingredient from a solid to a liquid. For NP powder, incorporation involves dissolution in the selected oil premix. With NP SANIO, the formulator adds an existing liposomal dispersion.
The NP powder specification lists a melting point of 98–103°C. This describes the powder’s thermal transition on its own. Its recommended oil-phase processing temperature describes incorporation into a mixture. An ingredient can dissolve in a suitable solvent below its melting point, so the two values describe different physical conditions. The oil blend and NP concentration are part of the dissolution conditions; a melting-point value alone cannot identify which mixture will accommodate the intended dose.
Appearance follows the intended product format. A cream can be opaque, and a liposomal ingredient can contribute to a serum’s appearance. Clarity is therefore only one part of assessing incorporation. A fine dispersion and a molecular solution can both look uniform to the eye. The relevant question is whether the selected ceramide format remains compatible with the surrounding formula during cooling and storage.
A hot-processed cream can accommodate NP powder within its oil phase. An aqueous serum or a cool-down addition stage favors a prepared dispersion. Both routes supply NP, with different carrier contributions and handling requirements. For formulation planning, the main distinction is whether the formulator dissolves the powder during processing or adds NP in a preformed carrier.
A fixed emollient blend adds another consideration. The powder uses that blend as its dissolution medium; NP SANIO brings additional carrier ingredients into the formula. A decision to change formats therefore affects the surrounding composition as well as the addition stage. The preferred option is the one that fits the formulation’s NP target without creating an incompatible carrier or an impractical heating step.
Ceramide NP powder has a specified HPLC assay of at least 95%, with a suggested use level of 0.05–0.5%. For this powder, we recommend dissolution in the oil phase at 85–95°C and advise against rapid cooling. Those instructions apply to the supplied powder grade.
The powder gives formulators control over the NP dose and the choice of surrounding oils. This is useful in a cream or lotion that already includes a heated oil phase. The formula’s emollient blend can be selected around its intended texture, with NP incorporated into that blend. Any additional barrier lipids can also be chosen separately. The powder is therefore a practical option for projects that specify NP without requiring a preselected combination of ceramides.
The oil premix contains only part of the total batch, so the NP concentration at this stage is higher than its percentage in the finished product. The actual oil proportions determine the environment in which dissolution takes place. Adding extra oil solely to assist dissolution changes the formula and its sensory profile. The powder route consequently works best when the intended oil blend and heating step can accommodate the selected NP level. Its high assay identifies a raw-material quality characteristic; compatibility with the oil phase remains a formulation requirement.
AC-Ceramide NP SANIO contains 5.0 ±0.5% NP in a water-dispersible liposomal format. The suggested use level is 1–10%, with gentle mixing below 45°C. This allows NP to enter an aqueous serum or the cool-down stage of an emulsion as a prepared dispersion.
Our nanoliposome encapsulation technology addresses NP’s low solubility and tendency to crystallize by supplying it in a carrier-based form. The practical advantage is that the formulator receives NP with its delivery system already prepared. This removes the need for a separate hot-oil premix specifically for the ceramide-addition step. The grade therefore suits formulas that use a cool-down aqueous addition route.
The carrier ingredients enter the formula along with NP and form part of its composition. A higher dispersion dose adds more of both. In a serum, those carrier ingredients should also be considered when evaluating clarity, body, and skin feel. The complete INCI identifies what accompanies the active, allowing the formulator to account for the commercial ingredient as a whole. For a cream or lotion, add NP SANIO during cool-down below 45°C with gentle mixing, and validate the complete emulsion process separately. The grade provides a different route for introducing NP, with final appearance assessed in the complete formula.

At the nominal 5.0% NP content of our AC-Ceramide NP SANIO, a 2% ingredient addition contributes 0.10% NP by weight to the finished formula:
2% × 5.0% = 0.10%
The 2% dose is the amount of the complete commercial dispersion. The balance of the 2% addition consists of carrier ingredients. This is a formulation calculation, not a recommended efficacy level. The suggested use ranges for the powder and dispersion refer to different commercial ingredients. Comparing those percentages alone can be misleading; each ingredient’s NP content is needed to calculate the active dose.
Replacing that dispersion with the same weight of powder would change the NP dose substantially. A switch between formats also changes the ingredients surrounding NP and the step at which it is introduced. Equal NP content provides a basis for comparing the active dose; the accompanying carrier still needs a place in the formula. Once the dose and carrier are defined, the next question is whether the selected system keeps NP incorporated during cooling and storage.
Recrystallization occurs when previously dissolved material forms crystals again. Cooling or a change in the surrounding ingredients can reduce the amount of ceramide a solvent system can retain. Material in excess of that capacity can then nucleate and grow into crystals. NP concentration and oil composition are therefore relevant to the behavior of a powder-based formula after the initial dissolution step.
A higher NP level increases the amount of ceramide that the same oil blend must retain. Replacing an emollient changes the solvent environment, even when total oil content stays constant. The aqueous phase, emulsifiers, and other ingredients further alter the environment when the premix becomes an emulsion. For the powder route, the selected oil blend and cooling conditions remain important as the batch moves from a hot premix to the finished cream. The processing guidance for the supplied powder therefore includes a cooling precaution.
NP SANIO changes the starting form by introducing ceramide through liposomes. Its carrier becomes part of the complete formulation, where compatibility still matters. Haze after adding a dispersion does not by itself identify NP crystals. Particles seen during or immediately after addition may instead reflect incomplete incorporation or the presence of other materials. The timing of a change helps locate the stage involved, but particle identity requires evidence beyond appearance. This keeps the focus on the actual defect without treating every cloudy serum or grainy cream as the same problem.
Ceramide NP is insoluble in water and has limited solubility in cosmetic carrier systems. Suitable oil-phase formulations can accommodate dissolved NP, and liposomal carriers provide a water-dispersible form for aqueous incorporation.
The suggested process for Ceramide NP Powder is oil-phase dissolution at 85–95°C, avoiding rapid cooling. The suggested ingredient use level is 0.05–0.5%.
A water-dispersible grade such as AC-Ceramide NP SANIO can be used; unformulated Ceramide NP does not dissolve in water. NP SANIO is added with gentle mixing below 45°C, and its appearance and texture should be evaluated in the complete serum base.
Appearance alone cannot confirm NP crystallization. Check when the particles appear and rule out incomplete dispersion or other ingredients before identifying Ceramide NP as the cause.
Finished-formula NP (%) = ingredient addition (%) × NP content (%) ÷ 100. When the COA reports a measured, batch-specific NP content by weight, that result can be used for a batch-specific calculation.
Once the formulation route and troubleshooting steps are defined, the selected commercial grade must remain traceable through production and supply. Our QA and QC system covers supplier audits, raw-material inspection, in-process controls, finished-product testing, and traceability. Quality checks extend across raw materials, intermediates, and finished products, with laboratory capabilities that include HPLC.
For an NP project, specifying the exact commercial grade keeps production records tied to the material used in formulation development. The powder’s assay specification describes a different supplied material from NP SANIO’s declared NP content and carrier composition. Keeping that distinction in purchasing information preserves the selected ingredient identity when moving from samples to routine supply. A proposed format change can then be assessed against the NP dose and carrier already used in the formula.
Type-specific TDS, SDS/MSDS, specifications, complete INCI information, and a recent COA sample are available for evaluation. Sample and quotation requests can be submitted with the intended application and processing constraints. We also provide type-selection support, formulation guidance, and compatibility guidance to help match the ceramide format to the formula’s texture, process temperature, and phase constraints. These details help determine whether powder incorporation or a liposomal addition route fits the project.